Single low-dose primaquine for malaria control in Africa: a systematic review of safety, efficacy and implementation barriers

Since 2012, the WHO has recommended a single low dose of primaquine (SLDPQ, 0.25 mg/kg) alongside artemisinin-based combination therapies (ACTs) to block Plasmodium falciparum transmission and combat artemisinin resistance. Despite its proven benefits, SLDPQ adoption in African malaria policies rema...

Full description

Saved in:
Bibliographic Details
Main Authors: Alphonse Ouedraogo, Sodiomon Bienvenu Sirima, Joseph Nyandwi, Didier Ménard, Tianle Ye, Emmanuelle Caspar, Denis Niyomwungere, Lucas Thiebaut, Pierre-Emeric Strubel, Omega Raobela, Rianasoambolanoro Rakotosaona, Arsène Ratsimbasoa
Format: Article
Language:English
Published: BMJ Publishing Group 2025-08-01
Series:BMJ Global Health
Online Access:https://gh.bmj.com/content/10/8/e020264.full
Tags: Add Tag
No Tags, Be the first to tag this record!